A safer way of altering genes

October 19, 1999

MICE engineered to carry an extra artificial chromosome have successfully passed it to their offspring. Although the Canadian company responsible has no intention of repeating the experiments in people, its work shows that human germline gene therapy-making genetic changes that will be inherited by future generations-is becoming a practical possibility.

Chromos Molecular Systems of Burnaby, British Columbia, reported the breakthrough this week in London at a conference on biotechnology. "It's the first time an artificial chromosome has ever been shown to be inherited in any mammal," says Eileen Utterson, vice-president of corporate development. Chromos plans to use the technology to create herds of genetically modified animals whose milk will contain pharmaceuticals.

Geneticists have been creating transgenic animals for years by injecting genes into a newly fertilised embryo. When this method works, every cell in the animal that develops from the embryo will contain the added genes, including its sperm and eggs. This means that the genes will be inherited by the transgenic animals' offspring.

It's a haphazard process, however. Often the gene doesn't get incorporated into the embryo's genome. And when it is, the gene splices itself at random into one of the animal's chromosomes, where it may not work as normal or, worse still, can disrupt other genes-potentially causing developmental abnormalities.

While occasional "mistakes" are tolerated in animal experiments, the danger of causing congenital defects is one of the reasons why germline gene therapy for people has remained taboo. So instead of trying to correct genetic defects such as the mutations that cause cystic fibrosis at the start of life-by adding genes to embryos created by IVF-gene therapists treat people with genetic disorders by adding therapeutic genes to specific tissues in the hope that they will be taken up by enough cells to correct the defect.

While this ensures that sperm and egg cells do not become contaminated by the added genes, it isn't very efficient. As a result, many gene therapy trials have had only limited success.

However, if genes could be ferried into embryos in an artificial chromosome that would safely be inherited without interfering with the rest of the genome, germline gene therapy might not be so risky. Chromos's experiments with mice suggest that this should be possible. "Because the artificial chromosome is separate, it doesn't interfere with the cell's own genetic machinery," says Utterson.

In London this week, Chromos presented preliminary results of experiments with mice given an artificial chromosome. By taking cell samples and exposing them to fluorescent dyes that bind to different parts of the chromosome, Chromos's scientists were able to discover which animals had accepted the chromosome. When the mice carrying the extra chromosome were crossed with normal mice, it was inherited in exactly the same way as the animals' natural chromosomes.

Chromos is also working on human artificial chromosomes for use in conventional, non-germline gene therapy. Artificial chromosomes will have an advantage here as well, because they can carry much more DNA than is possible with existing methods, which use viruses or loops of bacterial DNA known as plasmids. But the company says it won't let its technology be used for human germline engineering. "We are in control of the technology, and we don't want to engage in germline gene therapy," stresses Utterson.

However, many groups worldwide are also striving to create artificial human chromosomes. And some geneticists are talking openly of one day using such chromosomes for germline gene therapy (New Scientist, 3 October 1998, p 24).

"This is obviously going to open up the debate again in the field of germline gene therapy," says Norman Nevin of Belfast City Hospital, who chairs Britain's Gene Therapy Advisory Committee.

However, scientists advising the world's governments remain cautious. Claudia Mickleson of the Massachusetts Institute of Technology, who chairs the US National Institutes of Health's Recombinant DNA Advisory Committee, says that her committee wouldn't approve a germline trial without extensive preclinical information on safety. And given concerns about the technology being used to create "designer babies", Mickleson also says trials would not proceed without "intense discussion" with the public .
-end-
Author: Andy Coghlan
Issue 23rd October 99

PLEASE MENTION NEW SCIENTIST AS THE SOURCE OF THIS STORY AND, IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO : http://www.newscientist.com

New Scientist

Related DNA Articles from Brightsurf:

A new twist on DNA origami
A team* of scientists from ASU and Shanghai Jiao Tong University (SJTU) led by Hao Yan, ASU's Milton Glick Professor in the School of Molecular Sciences, and director of the ASU Biodesign Institute's Center for Molecular Design and Biomimetics, has just announced the creation of a new type of meta-DNA structures that will open up the fields of optoelectronics (including information storage and encryption) as well as synthetic biology.

Solving a DNA mystery
''A watched pot never boils,'' as the saying goes, but that was not the case for UC Santa Barbara researchers watching a ''pot'' of liquids formed from DNA.

Junk DNA might be really, really useful for biocomputing
When you don't understand how things work, it's not unusual to think of them as just plain old junk.

Designing DNA from scratch: Engineering the functions of micrometer-sized DNA droplets
Scientists at Tokyo Institute of Technology (Tokyo Tech) have constructed ''DNA droplets'' comprising designed DNA nanostructures.

Does DNA in the water tell us how many fish are there?
Researchers have developed a new non-invasive method to count individual fish by measuring the concentration of environmental DNA in the water, which could be applied for quantitative monitoring of aquatic ecosystems.

Zigzag DNA
How the cell organizes DNA into tightly packed chromosomes. Nature publication by Delft University of Technology and EMBL Heidelberg.

Scientists now know what DNA's chaperone looks like
Researchers have discovered the structure of the FACT protein -- a mysterious protein central to the functioning of DNA.

DNA is like everything else: it's not what you have, but how you use it
A new paradigm for reading out genetic information in DNA is described by Dr.

A new spin on DNA
For decades, researchers have chased ways to study biological machines.

From face to DNA: New method aims to improve match between DNA sample and face database
Predicting what someone's face looks like based on a DNA sample remains a hard nut to crack for science.

Read More: DNA News and DNA Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.